Response to the letter to the editor: Comparison of intravitreal aflibercept and ranibizumab injections on subfoveal and peripapillary choroidal thickness in eyes with neovascular age-related macular degeneration

被引：0
|
作者：
Cheolmin Yun
Jaeryung Oh
机构：
[1] Korea University College of Medicine,Department of Ophthalmology
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2016年 / 254卷
关键词：
Optical Coherence Tomography; Diurnal Variation; Axial Length; Ranibizumab; Macular Degeneration;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2067 / 2067
相关论文
共 50 条
  • [21] INTRAVITREAL AFLIBERCEPT IN EYES WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION RESISTANT TO INTRAVITREAL RANIBIZUMAB
    Narayan, Daniel
    Muecke, James
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 42 : 119 - 119
  • [22] Subfoveal choroidal thickness changes after intravitreal bevacizumab therapy for neovascular age-related macular degeneration
    Unlu, Cihan
    Erdogan, Gurkan
    Gunay, Betul Onal
    Akcay, Betul Ilkay Sezgin
    Kardes, Esra
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2015, 8 (04) : 849 - 851
  • [23] Subfoveal choroidal thickness changes after intravitreal bevacizumab therapy for neovascular age-related macular degeneration
    Cihan ünlü
    Gurkan Erdogan
    Betul Onal Gunay
    Betul Ilkay Sezgin Akcay
    Esra Kardes
    International Journal of Ophthalmology, 2015, (04) : 849 - 851
  • [24] Change in choroidal thickness after intravitreal aflibercept in pretreated and treatment-naive eyes for neovascular age-related macular degeneration
    Mazaraki, Kyriaki
    Fassnacht-Riederle, Heidi
    Blum, Robert
    Becker, Matthias
    Michels, Stephan
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2015, 99 (10) : 1341 - 1344
  • [25] Intravitreal aflibercept for neovascular age-related macular degeneration
    Xu, David
    Kaiser, Peter K.
    IMMUNOTHERAPY, 2013, 5 (02) : 121 - 130
  • [26] Intravitreal aflibercept in neovascular age-related macular degeneration with limited response to ranibizumab: a treat and extend trial
    Hatz, Katja B.
    Pruente, Christian
    Binningen, Vistaklinik
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [27] Subfoveal Choroidal Thickness as a Potential Predictor of Visual Outcome and Treatment Response After Intravitreal Ranibizumab Injections for Typical Exudative Age-Related Macular Degeneration
    Kang, Hae Min
    Kwon, Hee Jung
    Yi, Jeong Ho
    Lee, Christopher Seungkyu
    Lee, Sung Chul
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2014, 157 (05) : 1013 - 1021
  • [28] VISUAL AND ANATOMIC OUTCOMES OF INTRAVITREAL AFLIBERCEPT IN EYES WITH PERSISTENT SUBFOVEAL FLUID DESPITE PREVIOUS TREATMENTS WITH RANIBIZUMAB IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Fung, Adrian T.
    Kumar, Nishant
    Marsiglia, Marcela
    Mrejen, Sarah
    Slakter, Jason
    Sorenson, John
    Freund, K. Bailey
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 41 : 51 - 51
  • [29] VISUAL AND ANATOMICAL OUTCOMES OF INTRAVITREAL AFLIBERCEPT IN EYES WITH PERSISTENT SUBFOVEAL FLUID DESPITE PREVIOUS TREATMENTS WITH RANIBIZUMAB IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Kumar, Nishant
    Marsiglia, Marcela
    Mrejen, Sarah
    Fung, Adrian Tien-Chin
    Slakter, Jason
    Sorenson, John
    Freund, K. Bailey
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2013, 33 (08): : 1605 - 1612
  • [30] Association between choroidal thickness and the response to intravitreal ranibizumab injection in age-related macular degeneration
    Shin, Joo Youn
    Kwon, Kye Yoon
    Byeon, Suk Ho
    ACTA OPHTHALMOLOGICA, 2015, 93 (06) : 524 - 532
12345